Cargando…
The RGS2 (-391, C>G) Genetic Variation Correlates to Antihypertensive Drug Responses in Chinese Patients with Essential Hypertension
OBJECTIVE: Regulators of G-protein signaling protein 2 (RGS2) play an irreplaceable role in the control of normal blood pressure (BP). One RGS2 (-391, C>G) genetic variation markedly changes its mRNA expression levels. This study explored the relationship between this genetic variation and the re...
Autores principales: | He, Fazhong, Luo, Jianquan, Zhang, Zhitao, Luo, Zhiying, Fan, Lan, He, Yijing, Wen, Jiagen, Zhu, Dingilang, Gao, Jinping, Wang, Yan, Qian, Yuesheng, Zhou, Honghao, Chen, Xiaoping, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388730/ https://www.ncbi.nlm.nih.gov/pubmed/25849301 http://dx.doi.org/10.1371/journal.pone.0121483 |
Ejemplares similares
-
The KCNH2 Genetic Polymorphism (1956, C>T) Is a Novel Biomarker That Is Associated with CCB and α,β-ADR Blocker Response in EH Patients in China
por: He, Fazhong, et al.
Publicado: (2013) -
Polytropic Influence of TRIB3 rs2295490 Genetic Polymorphism on Response to Antihypertensive Agents in Patients With Essential Hypertension
por: Zhou, Jiecan, et al.
Publicado: (2019) -
Vascular microarray profiling in two models of hypertension identifies caveolin-1, Rgs2 and Rgs5 as antihypertensive targets
por: Grayson, T Hilton, et al.
Publicado: (2007) -
Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment
por: He, Fazhong, et al.
Publicado: (2016) -
Corrigendum to “Assessment of Human Tribbles Homolog 3 Genetic Variation (rs2295490) Effects on Type 2 Diabetes Patients with Glucose Control and Blood Pressure Lowering Treatment” [EBioMedicine 13 (2016) 181–189]
por: He, Fazhong, et al.
Publicado: (2017)